2024-12-24 08:17:04
EMA Validates Marketing Authorization Application for Henlius' HANSIZHUANG (Serplulimab)
Corporate/ 2023-07-24
EMA Validates Marketing Authorization Ap...

HANSIZHUANG (serplulimab) is the first anti-PD-1 mAb for the first-line treatment of small cell lung cancer (SCLC)

Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director
Corporate/ 2023-07-24
Clarivate Announces Gordon Samson as Pre...

Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release